H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act.Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act.
Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act.
Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009.
Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.
Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009.
Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009.
Response to congressional investigation regarding ENHANCE study.
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
S.260.Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Duration: January 1, 2008
to
November 3, 2009
General Issues: Copyright/Patent/Trademark , Labor Issues/Antitrust/Workplace , Health Issues , Medicare/Medicaid , Taxation/Internal Revenue Code , Animals
Spending: about $4,120,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2009
SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. in-house lobbying effort was terminated on Nov. 18, 2009
Original Filing: 300225202.xml
Lobbying Issues
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act.Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act.
Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act.
Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009.
Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.
Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009.
Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.260.Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. in-house lobbying effort was terminated on Nov. 18, 2009
Original Filing: 300225198.xml
Lobbying Issues
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act.Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act.
Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act.
Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009.
Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.
Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009.
Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.260.Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300220600.xml
Lobbying Issues
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act.Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act.
Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act.
Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009.
Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.
Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009.
Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.260.Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2009
In Q2, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300192798.xml
Lobbying Issues
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act.Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act.
Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act.
Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009.
Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.
Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009.
Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislative proposals that would increase the Medicaid drug price rebate. (none yet introduced in this Congress)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.260.Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2009
In Q1, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300164642.xml
Lobbying Issues
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act.Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act.
Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009.
Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009.
Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009.
Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009.
Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.260.Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2008
In Q4, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300132390.xml
Lobbying Issues
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.6432, To amend the Federal Food, Drug, and Cosmetic Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.6432, To amend the Federal Food, Drug, and Cosmetic Act to revise and extend animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act; S.3463, A bill to amend the trade Act of 1974; S.3600, A bill to amend Title 35 US Code. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007; S.3463, A bill to amend the Trade Act of 1974 to improve the international protection and enforcement of intellectual property rights, and for other purposes; S.3600, A bill to amend title 35 US Code, to provide for patent reforms.
Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act.
Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act.
Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300108143.xml
Lobbying Issues
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act.Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007.
Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act.
Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act.
Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300080594.xml
Lobbying Issues
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act.Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007.
Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act.
Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act.
Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300053434.xml
Lobbying Issues
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act.Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007.
Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act.
Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act.
Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008.
Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007.
Response to congressional investigation regarding ENHANCE study.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States.
Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...